Background: I he purposes of study was to compare world incidence of ovarian tumours whether benign or malignantwith that of ‘our unit. We have also discussed management of all these patients at our center. Results: In our unit outof total 1400 admissions in 24 months. 26 had ovarian tumours, out of these 6 were malignant. The overall malignancyin our unit was 23% as compared to 15% of overall world incidence 24 of these patients, were admitted through theOPD with advanced size of tumours. None of them previously had any checkup at proper Gynecological Centers. AHthese 24 were admitted to the ward, investigated, operated and after receiving histopathology reports were furthermanaged accordingly. Two patients had torsion of ovarian tumour and were admitted through emergency and operatedas emergency cases in our study group the majority. 77% had benign ovarian tumours in which simplesalpingoophorectomies was performed.


Pell KR Benign and Malignant Tumour of the ovary.

Dewhurt’s textbook of Obstetrics and Gynaecology for

Postgraduate (5th Edition) Chapter 49, pp. 759-779.

Vicki V, Baker MD, Premalignant and malignant

disorders of the ovaries and oviducts. Current Obstetric

& Gynecologic Diagnosis and treatment (Eight Edition)

Prentice-Hall International. Inc., 1994, pp. 954-966.

Beral 1978. The Epidemiology of ovarian cancer, in

ovarian cancer – the way ahead. RCOG, London.

Gordon V, Navaynshi, Grant P, Cumming and David E.,

Parkin. The performance of screening test for ovarian

cancer of systemic review ((correspondence). Br. J Obs

and Gynecology, 1999, Vol 106; (10) 1107-1108.

Morgante G, Lamrca A, Delco L. Comparison of the

malignancy risk indces based serum CA125, ultrasound

score and menopausal status in the diagnosis of ovarian

amasses. Br J of Obs and Gynae Vol. 106 June 1999 pp,


Fathalla M.F. Incessant ovulation a factor in ovarian

neoplasia. Lancet 1971: ii, 163.

Kottmeir h (1982). Annual Report on the results of

treatment of gynecological cancer. No. 18, FICO,

Stockholm, Sweden.

Griffiths C.T. Surgical resection of tumour bulk in the

primary treatment of ovarian carcinoma. Nati Cancer inst

Monogr. 1975: 42, 101-104.

Jacos l.J, Stabile l, Bridges J, Multimodal approach to

screening for ovarian cancer. Lancet 1988: 1 268-271.

Jacobs I J., Stabile l, & Bast R.C. The CA125 tumourassociated antigen a review of the literature. Hum

Reprod 1989; 1:1-12.

Jacos l.J. & Oram D.H. (1990). Potential screening tests

for ovarian cancer. In Ovarian Cancer: Biological and

Therapeutic Challenges (F. Sharpe, W.P, Nason & R.E.

Leak, eds), Chapman and Hall, London, 197-205.

Herman U, Locher G, & Goldhiresch A. 1987.

Sonographic pattern of ovarian tumours: predication of

malignancy. Obstet Gynecol 69, 777-781.

Bourne. Screening for early familial ovarian cancer with

transvaginal ultrasonography and color flow imaging.

Br. Med J 1993: 306, 1025-1029.

Bourne. Ca ovarian masses be characterized using

ultrasound. Gynecol Oncol 1993; 51-4-6.

Kurjak A., Zalud l & Alfirecic Z., Evacuation of adnexal

masses with transvaginal colour ultrasound. J.

Ultrasounds Med 1991: 10, 295-297.

Suzuki M. Macrophage colony-stimulating factor as a

tuour marker for epithelial ovarian cancer. Obstet

Gynecol 1993; 946-50.

Saski H, Moda Ohmuru, Akiama M, Cliu et al. Ovarian

cyst detected by transvaginal sonography in the Tokyo

metropolitan area. Br. J of Gynea ad Obstetrics, May

Vol. 106 415-420.

Most read articles by the same author(s)

1 2 > >>